Primary treatment with vincristine, dactinomycin and cyclophosphamide in nondysgerminomatous germ cell tumor of the ovary
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 34 (2) , 155-158
- https://doi.org/10.1016/0090-8258(89)90132-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatinCancer, 1986
- Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamideCancer, 1985
- Combination chemotherapy with cisplatin, vinblastine, and bleomycin for endodermal sinus tumor of the ovaryGynecologic Oncology, 1984
- Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.Journal of Clinical Oncology, 1983
- GERM-CELL MALIGNANCIES OF THE OVARY1979
- Improved prognosis in children with ovarian cancers following modified VAC (vincristine sulfate, dactinomycin, and cyclophosphamide) chemotherapyCancer, 1978
- Treatment of malignant ovarian germ cell tumors.Response to vincristine, dactinomycin, and cyclophosphamide (preliminary report)Cancer, 1978
- Immature (malignant) teratoma of the ovary.A clinical and pathologic study of 58 casesCancer, 1976
- Advances in chemotherapy for gynecologic cancerCancer, 1975